期刊文献+

坎地沙坦与培哚普利治疗老年高血压病的疗效观察 被引量:3

Effects of Candesartan compared with Perindopril in elderly hypertensive patients
下载PDF
导出
摘要 目的:探讨坎地沙坦联合苯磺酸氨氯地平治疗老年高血压病的疗效、安全性及对代谢指标的影响。方法:老年高血压病患者单独服用苯磺酸氨氯地平片5mg/d,2周后血压未降至150/90mmHg以下者70例,随机分为两组,坎地沙坦联合组36例,每日晨加服坎地沙坦8mg;培哚普利联合组34例,每日晨加服培哚普利4mg,两组疗程均为8周,观察联合用药前后动态血压变化,血尿酸及胱抑素-C变化。结果:第8周末,两组血压水平均较分组前降低(P<0.001),坎地沙坦联合组收缩压及舒张压下降幅度大于培哚普利联合组(P<0.05),两组脉压缩小程度间差异无统计学意义(P>0.05)。两组血尿酸及胱抑素-C水平均较观察前降低(P<0.001),坎地沙坦联合组血尿酸及胱抑素-C下降幅度均大于培哚普利联合组。结论:坎地沙坦联合苯磺酸氨氯地平能有效降低老年高血压病患者的血压水平,缩小脉压,降低血尿酸及胱抑素-C水平。 Objective:To evaluate the safety and efficacy of Candesartan plus Amlodipine Besylate in elderly patients with hypertension.Methods:The elderly patients with hypertension took Amlodipine Besylate 5 mg daily alone.After two weeks' treatment,70 cases with blood pressure over 150/90 mm Hg were randomly divided into two groups,36 cases of Candesartan group treated with Candesartan 8 mg daily;34 cases of Perindopril group treated with Perindopril 4 mg daily,they were treated for 8 weeks,the ambulatory blood pressure,blood uric acid and cystatin-C of two groups were compared.Results:After 8 weeks' treatment,the blood pressure of two groups reduced,the differences were statistically significant(P0.001),the decrease range of SBP and DBP in the Candesartan group were more than those of the Perindopril group(P 0.05),the PP was also reduced in the two groups,but there was no significant difference(P0.05).In the two groups,the blood uric acid and cystatin-C were lower than those before treatment(P0.001),the decrease range of blood uric acid and cystatin-C in the Candesartan group were more than those of the Perindopril group.Conclusion:Candesartan combined Amlodipine Besylate can effectively reduce blood pressure and pulse pressure in elderly hypertensive patients,and can effectively reduce the lever uric acid and cystatin-C.
出处 《中国医药导报》 CAS 2010年第17期53-56,共4页 China Medical Herald
关键词 老年 高血压 坎地沙坦 培哚普利 平滑指数 Elderly Hypertension Candesartan Perindopril Soomthness index
  • 相关文献

参考文献15

  • 1孙宁玲.优化降压治疗方案在高血压治疗中的意义——ASCOT-BPLA研究解读[J].中国实用内科杂志,2007,27(6):416-418. 被引量:17
  • 2Hansson L,Lindholm LH,Ekbom T.Randomised trial of old and antihupertensive drugs in eldly patients:cardiovasoubrmortality andmorbidity the Swedish Trialin inold patients with hypertension-2 study[J].Lancet,1999,354(9192):1751-1756.
  • 3PBOGRESS Collaborative Study Group.Randomised trial of perindopril based blood pressure-loweringimen among 6105 individuals with previous stoke or transient ischaemic attack[J].Lancet,2001,358:1033-1041.
  • 4Beckett NS,Peters R,Fietcher AE,et al.Treatment of hypertension in patients 80 years of age or older[J].N Engl J Med,2008,358:1887-1898.
  • 5赵秀丽.血管紧张素转换酶抑制剂与血管紧张素Ⅱ受体拮抗剂在原发性高血压治疗中的临床应用[J].临床药物治疗杂志,2007,5(5):11-15. 被引量:8
  • 6Suaruta T,Hayashi K,Ogihara T,et al.Effects of candesartan and amlodipine on cardiovascular events in hypertensive patients with chronic kidney disease:subanalysis of the CASJ study[J].N Engl J Med,2008,359(12):1238-1251.
  • 7Liu LS,Wang JL Gong L,et al.Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertemion[J].JHypertensions,1998,16:1823-1829.
  • 8Staeseen JA,Fagard R,Thijs L,et al.Systoic Hypertension in comparison of placebo and active treatment for older patients with isolated systolic hypertension[J].Lancet,1997,350:757-764.
  • 9周春绵,王陆建.血压变异性的机制和临床意义[J].临床荟萃,2003,18(11):657-658. 被引量:8
  • 10Faiez Zannad,Anca Radaucesnu,Gianfranco Parati.Trough-to-peak ratio,smoothness index and morning-to-evening ratio:why,which and when?[J]J Hyperens,2003,21:851-854.

二级参考文献22

  • 1胡大一,赵秀丽.血管紧张素Ⅱ受体拮抗剂治疗高血压的研究进展[J].现代康复,1999,3(10):1204-1206. 被引量:6
  • 2赵秀丽.高血压药物治疗进展[J].临床药物治疗杂志,2005,3(3):15-18. 被引量:7
  • 3无.血管紧张素转换酶抑制剂在心血管病中应用中国专家共识[J].中华心血管病杂志,2007,35(2):97-106. 被引量:133
  • 4[1]Coll E, Botey A, Alvarez L, et al. Serum cystatin C as new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis, 2000, 36(1) :29 - 34.
  • 5[3]Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis, 2001,37(1):79-83.
  • 6[4]Newman DJ, Thankkar H, Robert G, etal. Serum cystatin C measured by automated immunoassay. A more sensitive marker of changes in GFR than serum creatinine. Kidney Int, 1995, 47:312-318.
  • 7Mancia G, Grassi G. Mechanisms and clinical implications of blood pressure variability[Jl. J Cardiovasc Pharmacol, 2000,35(Suppl 4):15-19.
  • 8Kikuya M, Hozawa A, Ohokubo T, et al. Prognostic significance of blood pressure and heart rate variabilities: the ohasama study[J]. Hypertension,2000,36(5):901-906.
  • 9Sega R, Cesana G, Bombelli M, et al. Seasonal variations in home and ambulatory blood pressure in the PAMELA population[J]. J Hypertens, 1998,16(7) : 1585-1592.
  • 10Mancia G, Parati G, Di Rienzo M, et al. Blood pressure variability. In: Zanchetti A, Mancia G, eds. Handbook of hypertension[M]. Vol 17. Amsterdam: Elsevier Science, 1997.117-169.

共引文献38

同被引文献15

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部